Keyword Index

F

H

  • Hodgkin Lymphoma Does FDG PET/CT have Additional Diagnostic Accuracy of Surveillance in Detection of Early Relapse in Non- Hodgkin Lymphoma? [Volume 20, Issue 1, 2020, Pages 18-38]

I

  • Internal dosimetry Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]

M

  • Malignant Lymphoma & PET/CT & Pitfalls How Hybrid PET/CT Improve Pitfalls and Artifacts in Malignant Lymphoma? [Volume 20, Issue 1, 2020, Pages 64-81]
  • MIRDOSE Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]
  • Myocardial Perfusion Imaging Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]

O

  • OLINDA Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]

P

  • PET/CT Surveillance & Early Relapse & Non Does FDG PET/CT have Additional Diagnostic Accuracy of Surveillance in Detection of Early Relapse in Non- Hodgkin Lymphoma? [Volume 20, Issue 1, 2020, Pages 18-38]

S

  • SPECT Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. [Volume 20, Issue 1, 2020, Pages 82-93]